Lim J, Jung J, Kim Y, Kim C, Lee S, Park D
Biomedicines. 2025; 13(2).
PMID: 40002883
PMC: 11852785.
DOI: 10.3390/biomedicines13020470.
Klabukov I, Kabakov A, Yakimova A, Baranovskii D, Sosin D, Atiakshin D
Curr Oncol. 2025; 32(2).
PMID: 39996879
PMC: 11854105.
DOI: 10.3390/curroncol32020079.
Rafiq Z, Kang M, Barsoumian H, Manzar G, Hu Y, Leuschner C
J Exp Clin Cancer Res. 2025; 44(1):31.
PMID: 39881333
PMC: 11781074.
DOI: 10.1186/s13046-025-03281-2.
Sultan S, Gorris M, Martynova E, van der Woude L, Buytenhuijs F, van Wilpe S
Biol Methods Protoc. 2025; 10(1):bpae094.
PMID: 39866377
PMC: 11769680.
DOI: 10.1093/biomethods/bpae094.
Guo Z, Hong D, Wei Y, Huo Y, Su S, Shi Y
AME Case Rep. 2025; 9():17.
PMID: 39866256
PMC: 11760919.
DOI: 10.21037/acr-24-137.
Tumor-infiltrating lymphocytes in melanoma: from prognostic assessment to therapeutic applications.
Bida M, Miya T, Hull R, Dlamini Z
Front Immunol. 2024; 15:1497522.
PMID: 39712007
PMC: 11659259.
DOI: 10.3389/fimmu.2024.1497522.
Remolding the tumor microenvironment by bacteria augments adoptive T cell therapy in advanced-stage solid tumors.
Zhu C, Liu C, Wu Q, Sheng T, Zhou R, Ren E
Signal Transduct Target Ther. 2024; 9(1):307.
PMID: 39572541
PMC: 11582571.
DOI: 10.1038/s41392-024-02028-3.
Cold and hot tumors: from molecular mechanisms to targeted therapy.
Wu B, Zhang B, Li B, Wu H, Jiang M
Signal Transduct Target Ther. 2024; 9(1):274.
PMID: 39420203
PMC: 11491057.
DOI: 10.1038/s41392-024-01979-x.
Tumor draining lymph nodes connected to cold triple-negative breast cancers are characterized by Th2-associated microenvironment.
Guo W, Tan J, Wang L, Egelston C, Simons D, Ochoa A
Nat Commun. 2024; 15(1):8592.
PMID: 39366933
PMC: 11452381.
DOI: 10.1038/s41467-024-52577-y.
Tumor-derived DEFB1 induces immune tolerance by inhibiting maturation of dendritic cell and impairing CD8+ T cell function in esophageal squamous cell carcinoma.
Duan J, Wang H, Liu M, Chen Y, Li N, Liu J
Chin J Cancer Res. 2024; 36(4):351-367.
PMID: 39246704
PMC: 11377887.
DOI: 10.21147/j.issn.1000-9604.2024.04.01.
Tissue- and Temporal-Dependent Dynamics of Myeloablation in Response to Gemcitabine Chemotherapy.
Kitelinger L, Thim E, Zipkowitz S, Price R, Bullock T
Cells. 2024; 13(16.
PMID: 39195207
PMC: 11352862.
DOI: 10.3390/cells13161317.
RILPL2 as a potential biomarker for predicting enhanced T cell infiltration in non-small cell lung cancer.
Chen D, Zhang H, Zhao L, Liu X, Lou Y, Wu P
Immunol Res. 2024; 72(5):1174-1184.
PMID: 39078518
PMC: 11564405.
DOI: 10.1007/s12026-024-09520-6.
Revolutionizing Cancer Treatment: Unleashing the Power of Combining Oncolytic Viruses with CAR-T Cells.
Zhang L, Guo S, Chang S, Jiang G
Anticancer Agents Med Chem. 2024; 24(19):1407-1418.
PMID: 39051583
DOI: 10.2174/0118715206308253240723055019.
Deconstructing Intratumoral Heterogeneity through Multiomic and Multiscale Analysis of Serial Sections.
Schupp P, Shelton S, Brody D, Eliscu R, Johnson B, Mazor T
Cancers (Basel). 2024; 16(13).
PMID: 39001492
PMC: 11240479.
DOI: 10.3390/cancers16132429.
Prognostic and clinicopathological significance of systemic immune-inflammation index in upper tract urothelial carcinoma: a meta-analysis of 3911 patients.
Yu Z, Xiong Z, Ma J, Du P, Wang S, Liu J
Front Oncol. 2024; 14:1342996.
PMID: 38947894
PMC: 11211359.
DOI: 10.3389/fonc.2024.1342996.
Endothelial cell Notch signaling programs cancer-associated fibroblasts to promote tumor immune evasion.
Zhu Y, Xiang M, Brulois K, Lazarus N, Pan J, Butcher E
Res Sq. 2024; .
PMID: 38947054
PMC: 11213189.
DOI: 10.21203/rs.3.rs-4538031/v1.
MDM2/MDMX inhibition by Sulanemadlin synergizes with anti-Programmed Death 1 immunotherapy in wild-type p53 tumors.
Ingelshed K, Melssen M, Kannan P, Chandramohan A, Partridge A, Jiang L
iScience. 2024; 27(6):109862.
PMID: 38784022
PMC: 11112618.
DOI: 10.1016/j.isci.2024.109862.
Microphysiological systems as models for immunologically 'cold' tumors.
Gaebler D, Hachey S, Hughes C
Front Cell Dev Biol. 2024; 12:1389012.
PMID: 38711620
PMC: 11070549.
DOI: 10.3389/fcell.2024.1389012.
Migration of human T cells can be differentially directed by electric fields depending on the extracellular microenvironment.
Ende K, Santos F, Guasch J, Kemkemer R
iScience. 2024; 27(5):109746.
PMID: 38706849
PMC: 11067362.
DOI: 10.1016/j.isci.2024.109746.
Identification of prognostic m6A modification patterns and score system in melanoma patients.
Wang F, Chen P, Ouyang S, Xiong K, Liu Z, Wang Y
Medicine (Baltimore). 2024; 103(17):e37950.
PMID: 38669381
PMC: 11049698.
DOI: 10.1097/MD.0000000000037950.